Translation. Region: Russian Federation –
Source: Government of the Russian Federation – Government of the Russian Federation –
An important disclaimer is at the bottom of this article.
The Prime Minister reviewed the work and development plans of the National Medical Research Center of Hematology, inspected the laboratories and patient rooms, the drug production area, and the donor room, where he spoke with honorary donors.
The Institute of Blood Transfusion was established by a resolution of the USSR Council of Labor and Defense on February 26, 1926, becoming the first specialized institute of its kind in the world. Today, the National Medical Research Center of Hematology is a leading expert organization in Russia in the treatment of hematological diseases and blood transfusion. The center successfully treats oncological blood diseases that were recently considered incurable. The overall five-year survival rate, reflecting the effectiveness of the developed treatment programs, is 85% for lymphoma, 85% for multiple myeloma, 90% for aplastic anemia, and 60% for acute leukemia in patients under 60.
Scientific research and the professionalism of our staff, coupled with state-of-the-art equipment, have helped restore the health of hundreds of thousands of patients. The center performs over 1,500 surgical procedures annually, including on patients with bleeding disorders. The National Medical Research Center of Hematology is the country's leading transplant center, performing over 400 bone marrow transplants annually.
The center includes scientific and clinical laboratories, instrumental and radiation diagnostic departments, day hospitals, outpatient services, and a 270-bed hospital for the provision of specialized, including high-tech, medical care.
The National Medical Research Center of Hematology has accumulated extensive experience in successfully managing pregnancies in women with various forms of lymphoma, chronic myeloid leukemia, and other blood diseases.
The National Medical Research Center of Hematology participates in international clinical trials and organizes multicenter clinical trials in Russia.
The center implements postgraduate education and professional retraining programs.
Please note: This information is raw content obtained directly from the source. It represents an accurate account of the source's assertions and does not necessarily reflect the position of MIL-OSI or its clients.